Events & Presentations

Upcoming Events

Events coming soon

Past Events

4D Molecular Therapeutics to Participate at Upcoming Investor Conferences

Emeryville, CA – November 6, 2018 - 4D Molecular Therapeutics (4DMT), a world-leader in Therapeutic Vector Evolution for adeno-associated virus (AAV) gene therapy vector discovery and product development today announced that company management will participate at the following upcoming investor ...

4D Molecular Therapeutics to present at 2017 Cell & Gene Meeting on the Mesa

Emeryville, CA, October 4, 2017 – 4D Molecular Therapeutics announced today that David Kirn, MD, co-founder, Chairman & CEO will present at the annual Partnering Forum, part of the Cell & Gene Meeting on the Mesa to be held October ...

Co-Founder David Schaffer Presents AAV Directed Evolution Research

4D Molecular Therapeutics co-founder, Dr. David Schaffer, recently presented  an overview of his research entitled “Directed evolution of novel adeno-associated viral vectors for gene therapy” as a contribution to the Henry Stewart Talk Series titled “Gene Transfer and Gene Therapy”, part of ...